Pathology Research International metastases in breast cancer patients with a positive sentinel node biopsy,” Annals of Surgical Oncology, vol. 10, no. 10, pp. 1140–1151, 2003. [38] E. Barranger, C. Coutant, A. Flahault, Y. Delpech, E. Darai, and S. Uzan, “An axilla scoring system to predict non- sentinel lymph node status in breast cancer patients with sentinel lymph node involvement,” Breast Cancer Research and Treatment, vol. 91, no. 2, pp. 113–119, 2005. [39] Y. Y. Tan, Y. G. Fan, Y. Lu et al., “Ratio of positive to total number of sentinel nodes predicts nonsentinel node status in breast cancer patients,” Breast Journal, vol. 11, no. 4, pp. 248– 253, 2005. [40] S. M. Giobuin, D. O. Kavanagh, E. Myers et al., “The signiﬁcance of immunohistochemistry positivity in sentinel nodes which are negative on haematoxylin and eosin in breast cancer,” European Journal of Surgical Oncology, vol. 35, no. 12, pp. 1257–1260, 2009. [41] A. E. Giuliano, L. M. McCall, P. D. Beitsch et al., “ACOSOG Z0011: a randomized trial of axillary node dissection in women with clinical T1-2 N0 M0 breast cancer who have a positive SN,” Journal of Clinical Oncology, vol. 28, p. 18s, abstract CRA506, 2010. [42] O. Abe, R. Abe, K. Enomoto et al., “Eﬀects of radiotherapy and of diﬀerences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials,” The Lancet, vol. 366, no. 9503, pp. 2087– 2106, 2005. 7